A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib

Clinical trial NCT02873962 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02873962
Sponsor: Dana-Farber Cancer Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Peritoneal Cancer Ovarian Cancer Fallopian Tube Cancer

Start date: 2016-11-10
Primary completion: 2025-02-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.